Increased levels of Nectin-2 have also been found to be a biomarker for poor prognosis and metastatic disease in squamous cell and adenosquamous carcinoma and adenocarcinoma of the gallbladder [23]. This evidence concerns the gene NECTIN2 and metastatic neoplasm.